Christopher Hite - 05 Mar 2026 Form 4 Insider Report for Vera Therapeutics, Inc. (VERA)

Role: Director
Signature: /s/ Joseph R. Young, Attorney-in-Fact
Issuer symbol: VERA
Transactions as of: 05 Mar 2026
Net transactions value: $0
Form type: 4
Filing time: 09 Mar 2026, 16:49:21 UTC
Previous filing: 13 Feb 2026
SEC: View on sec.gov

Reporting Owners (1)

Name	Relationship	Address	Signature	Signature date	CIK
Hite Christopher	Director	C/O VERA THERAPEUTICS, INC., 2000 SIERRA POINT PARKWAY, SUITE 1200, BRISBANE	/s/ Joseph R. Young, Attorney-in-Fact	09 Mar 2026	0001814238

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	VERA	Stock Option (right to buy)	Award		+24,937		$0.000000^*	24,937	05 Mar 2026	Class A Common Stock	24,937	$38.85	Direct	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The shares subject to the option will vest monthly over a three-year period, subject to the Reporting Person's continuous service on each vesting date.